Large-scale testing (Phase 3)Active Not RecruitingNCT06506916
What this trial is testing
Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 89